TAYLOR SMITH: Open Payments
NPI 1194213025 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,174 in 49 payments from 9 companies in 2025. Trend: 2023 $2,287 · 2024 $2,141 · 2025 $1,174
Food & beverage: $1,174
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $347 |
| Alkermes, Inc. | 12 | $287 |
| Otsuka America Pharmaceutical, Inc. | 6 | $166 |
| Axsome Therapeutics, Inc. | 5 | $133 |
| Lundbeck LLC | 3 | $86 |
| ABBVIE INC. | 4 | $81 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Neos Therapeutics, LP | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: CAPLYTA, LYBALVI, REXULTI, Auvelity, VRAYLAR, ABILIFY MAINTENA, FANAPT, Adzenys XR-ODT.
Industry payments across TX — which companies pay providers there.
